This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Population Council, Inc.. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Rachida Guennoun: Innovator in Neuroprotection and Myelin Repair
Introduction
Rachida Guennoun is a prominent inventor based in Villejuif, France. She has made significant contributions to the field of neuroprotection and myelin repair, focusing on innovative methods for treating neurodegeneration.
Latest Patents
Rachida Guennoun holds two patents related to her groundbreaking work. Her latest patents involve methods for treating neurodegeneration and/or myelination in patients. These methods utilize a progestin compound that binds to progesterone receptors, eliciting biological responses without interacting with the androgen receptor. The progestin compound, specifically 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione, is combined with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration. These methods also address effects on stroke and traumatic brain injury (TBI).
Career Highlights
Rachida Guennoun is associated with The Population Council, Inc., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on treating neurodegenerative conditions.
Collaborations
Rachida collaborates with notable colleagues, including Regine Sitruk-Ware and Michael Maria Helmut Schumacher. Their combined expertise contributes to the advancement of research in neuroprotection and myelin repair.
Conclusion
Rachida Guennoun's innovative work in neuroprotection and myelin repair highlights her significant contributions to medical science. Her patents and collaborations reflect her commitment to advancing treatments for neurodegeneration.